-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyntra Bio prepays USD 42.6 million under amended royalty financing deal

PUBT·08/31/2026 20:07:40
Listen to the news
Kyntra Bio prepays USD 42.6 million under amended royalty financing deal
  • Kyntra Bio amended its royalty financing agreement with NQ Project Phoebus, cutting maximum aggregate payments to USD 65 million from USD 125 million.
  • Accelerated an upfront payment of USD 42.6 million, lifting total payments to USD 50 million, matching NQ Project Phoebus’ invested capital.
  • Future payments capped at USD 15 million, funded from 50% of revenue received from Astellas outside Japan in its territories.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyntra Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608311605PRIMZONEFULLFEED9818816) on August 31, 2026, and is solely responsible for the information contained therein.